Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autoimmune pancreatitis (AIP) is a rare pancreatic disease characterized by chronic non-alcoholic pancreatitis that presents with abdominal pain, steatorrhea, obstructive jaundice and responds well to steroid therapy and is seen in two subforms: type 1 AIP which affects elderly males, involves other organs and has increased immunoglobin G4 (IgG4) levels and type 2 AIP which affects both sexes equally but presents at a younger age and has no other organ involvement or increased IgG4 levels.
Biomarker and diagnostic research for autoimmune pancreatitis has been reported in the published literature.
5 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06369909](https://clinicaltrials.gov/study/NCT06369909) |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 1:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
— |
Peking Union Medical College Hospital |
UNKNOWN |
[NCT06753318](https://clinicaltrials.gov/study/NCT06753318) | Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions | NA | Huazhong University of Science and Technology | NOT_YET_RECRUITING |
[NCT06328101](https://clinicaltrials.gov/study/NCT06328101) | Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR) | — | University Medical Center Goettingen | UNKNOWN |
[NCT07015580](https://clinicaltrials.gov/study/NCT07015580) | The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis | — | Ruijin Hospital | RECRUITING |
[NCT07536841](https://clinicaltrials.gov/study/NCT07536841) | Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis | — | Military Medical Clinical Center of the Southern Region, Ukraine | RECRUITING |
222 publications have been identified in PubMed for autoimmune pancreatitis. Kisho has analyzed 148 by research type. Research spans Review / Meta-Analysis (28%), Case Report / Case Series (18%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 42 | 28% |
Patient case studies | 27 | 18% |
Disease patterns and progression | 24 | 16% |
Laboratory research | 19 | 13% |
Clinical study results | 17 | 11% |
Testing and diagnosis research | 16 | 11% |
Other research | 3 | 2% |
Iarossi M (2026). [PMID: 42097159](https://pubmed.ncbi.nlm.nih.gov/42097159/). *Hamostaseologie*. [Case Report / Case Series]
Kurita Y (2026). [PMID: 41780975](https://pubmed.ncbi.nlm.nih.gov/41780975/). *Intern Med*. [Clinical Trial Publication]
Teschke R (2026). [PMID: 42123570](https://pubmed.ncbi.nlm.nih.gov/42123570/). *Int J Mol Sci*. [Review / Meta-Analysis]
Goni E (2026). [PMID: 40829952](https://pubmed.ncbi.nlm.nih.gov/40829952/). *European journal of internal medicine*. [Clinical Trial Publication]
Alavi R (2026). [PMID: 42131673](https://pubmed.ncbi.nlm.nih.gov/42131673/). *Cureus*. [Case Report / Case Series]
Mahajne J (2026). [PMID: 41248980](https://pubmed.ncbi.nlm.nih.gov/41248980/). *Drug and therapeutics bulletin*. [Clinical Trial Publication]
Iglesia D (2026). [PMID: 42011215](https://pubmed.ncbi.nlm.nih.gov/42011215/). *EClinicalMedicine*. [Review / Meta-Analysis]
Facciorusso A (2026). [PMID: 41195006](https://pubmed.ncbi.nlm.nih.gov/41195006/). *DEN open*. [Case Report / Case Series]
Masamune A (2026). [PMID: 42154026](https://pubmed.ncbi.nlm.nih.gov/42154026/). *J Gastroenterol*. [Epidemiology / Natural History]
Kawakami Y (2026). [PMID: 41621879](https://pubmed.ncbi.nlm.nih.gov/41621879/). *Internal medicine (Tokyo, Japan)*. [Review / Meta-Analysis]
AI-curated news mentioning autoimmune pancreatitis
Updated Jul 27, 2026
A case report details nodal metastasis from an occult duodenal gastrinoma in a patient with overlapping xanthogranulomatous and type 1 autoimmune pancreatitis. This study contributes to the understanding of complex interactions between these rare conditions.
A recent study explores the correlation between autoimmune pancreatitis and IgG4-related cholangitis, highlighting the importance of radiologic and serologic assessments. This research contributes to the understanding of these autoimmune conditions and their interrelation.
Recent research provides insights into Type 3 Autoimmune Pancreatitis, highlighting its unique characteristics and potential treatment pathways. This study contributes to the understanding of autoimmune conditions affecting the pancreas.